Antimicrobial polypeptides like LL-37 and defensins, while fighting oral infections, may also promote oral cancer through growth receptor activation and tumor-promoting gene induction — linking periodontitis to oral squamous cell carcinoma.
Dual-role defense peptidesLL-37 and defensins both fight oral infections AND promote tumor growth — chronic periodontitis keeps them elevated, potentially tipping the balance toward cancer
What the researchers found
Antimicrobial polypeptides LL-37 and human defensins, along with S100 proteins and alarmins, can promote oral tumorigenesis through direct growth receptor binding and indirect tumor-promoting gene induction, potentially linking chronic periodontitis to oral squamous cell carcinoma.
Why it matters
Periodontitis affects nearly half of adults and oral cancer is the most common oral malignancy. Understanding that the body's own antimicrobial peptides — meant to fight infection — can inadvertently promote cancer reveals a molecular mechanism linking these two diseases and could lead to new prevention strategies.
The numbers in context
Periodontitis is highly prevalent and oral squamous cell carcinomas are the most common oral malignant lesions.
How the study worked
Narrative review synthesizing evidence on how innate host defense molecules (cathelicidin LL-37, defensins, S100 proteins, alarmins) participate in oral cancer development in the context of chronic periodontal inflammation.
Who was studied
Literature review
What this study cannot tell us
Review article without new experimental data. The causal links between AMP elevation, periodontitis, and oral cancer are largely associative and mechanistically plausible rather than definitively proven in humans. Individual AMP contributions are difficult to isolate in the complex oral inflammatory environment.
How to read the evidence
Moderate evidence as a review synthesizing multiple lines of research. The individual AMP-cancer mechanisms are well-documented in vitro, but the clinical significance of the periodontitis-oral cancer link via AMPs requires more epidemiological and interventional evidence.
When this study was published
Published in 2024, reflecting current understanding of the inflammation-cancer connection in the oral cavity.
The bigger picture
This review illustrates a broader principle in biology: molecules that protect us from infection can become harmful when chronically activated. The antimicrobial peptides that defend against oral bacteria are the same ones that, when persistently elevated by gum disease, create a tumor-promoting environment. This connects the global burden of periodontal disease to cancer risk and suggests that treating gum disease may have cancer-preventive benefits.
Questions still open
- Could treating periodontitis reduce oral cancer risk by lowering chronic AMP exposure?
- Are specific defensin or LL-37 gene variants associated with higher oral cancer risk?
- Could monitoring AMP levels in saliva serve as an early biomarker for oral cancer risk in periodontitis patients?
Common questions
Can gum disease really cause oral cancer?
What are LL-37 and defensins?
Read the original research
Role of innate host defense proteins in oral cancerogenesis.
Periodontology 2000, 96(1), 203-220
Citation
Winter, Jochen; Jepsen, Søren. (2024). Role of innate host defense proteins in oral cancerogenesis.. Periodontology 2000, 96(1), 203-220. https://doi.org/10.1111/prd.12552